Prospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Aug 7, 2015; 21(29): 8927-8934
Published online Aug 7, 2015. doi: 10.3748/wjg.v21.i29.8927
Table 1 Demographic and clinical data of the study population n (%)
VariablesPatients (n = 43)
Age (yr)
< 213 (30.2)
2-59 (20.9)
5-1011 (25.6)
> 1010 (23.3)
Female23 (53.5)
Nutritional status1
Well-nourished28 (65.1)
Risk of malnutrition10 (23.3)
Malnutrition5 (11.6)
Causes of chronic liver disease
Biliary atresia31 (72)
Alpha-1 antitrypsin deficiency6 (14)
Sinusoidal obstruction syndrome1 (2.3)
Idiopathic chronic liver disease1 (2.3)
Cirrhosis by cytomegalovirus1 (2.3)
Cryptogenic cirrhosis3 (7)
Cholestasis (CB ≥ 2.0 mg/dL)12 (27.9)
Albumin (< 3.5 g/L)12 (27.9)
Portal hypertension24 (55.8)
Ascites3 (7)
Hepatomegaly25 (58.1)
Splenomegaly32 (74.4)
Cirrhosis35 (81.4)
Child-Pugh score
A20/35 (57.1)
B12/35 (34.3)
C3/35 (8.6)
PELD score (> 15)4/27 (14.8)
MELD score (> 15)1/8 (12.5)
Table 2 Cytokine levels in children with chronic liver disease at nutritional risk vs well-nourished
CytokineNutritional riskWell-nourishedP value1
Interleukin-1β (pg/mL)0.10 (0-0.66)0.05 (0-0.28)0.144
Interleukin-6 (pg/mL)7.12 (0.58-34.23)1.63 (0.53-3.43)0.020
TNF-α (pg/mL)10.74 (8.17-12.35)6.66 (4.28-11.26)0.880
Table 3 Correlations between the interleukin-6 levels and routine liver function tests
Liver function testsMedian (25th-75th)rsP value
Aspartate aminotransferase (U/L)73.50 (49.25-177.00)0.70< 0.001
Alanine aminotransferase (U/L)60.00 (33.75-115.75)0.490.001
Conjugated Bilirubin (mg/dL)0.7 (0.2-2. 57)0.72< 0.001
Table 4 Multiple linear regression models for interleukin-6 levels adjusted for liver disease severity and nutritional status
Models1βP value
Child-Pugh score20.581< 0.001
PELD/MELD score30.5350.001